Transcripts
Iovance Biotherapeutics (IOVA) earnings call transcripts
Earnings call transcripts for Iovance Biotherapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.
- Q2 2026 earnings call
Management framed the quarter as proof that demand, manufacturing scale and cost discipline are improving together, while deferring revised full-year guidance until Q3 visibility improves.
Aug 06, 2026Confident0.82